Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

Market Cap	62.16B -12.8%
Revenue (ttm)	120.69B +6.5%
Net Income	22.29B -24.9%
EPS	n/a
Shares Out	12.91M
PE Ratio	2.79
Forward PE	n/a
Dividend	150.00 (3.09%)
Ex-Dividend Date	Dec 29, 2025

Volume	41,838
Average Volume	42,322
Open	4,855.00
Previous Close	4,865.00
Day's Range	4,820.00 - 4,905.00
52-Week Range	4,335.00 - 6,890.00
Beta	0.32
RSI	61.48
Earnings Date	n/a

About Jin Yang Pharmaceutical

Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers crivix tablets, Eszol tablets, atolan tablets, prescription drugs, and over-the-counter drugs. It also offers antilipidemic, antiplatelet, gastrointestinal, and respiratory agents; antithrombotics; NSAIDs; menopause symptoms treatment; and stomatological products. The company also exports its products. Jin Yang Pharmaceutical Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1971
• Employees: 220
• Stock Exchange: KOSDAQ
• Ticker Symbol: 007370

Financial Performance

In 2025, Jin Yang Pharmaceutical's revenue was 120.69 billion, an increase of 6.49% compared to the previous year's 113.33 billion. Earnings were 22.29 billion, a decrease of -24.95%.